GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Frequency of Eye Diseases in Subjects Aged 40 and Over. Open Journal of Ophthalmology, 15, 11-17. doi: ...
The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with ...
Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...
New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious concerns.
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback